Transcatheter Cardiovascular Therapeutics 2008 - Post Conference Review

Transcatheter Cardiovascular Therapeutics 2008 - Post Conference Review

Summary

Our “Transcatheter Cardiovascular Therapeuitics (TCT) Annual Meeting 2008 - Post Conference Review” report is an essential source of information and analysis on the conference. This will provide answers to questions like: what are the emerging trends in the interventional cardiology market? Which are the upcoming technologies and companies? Which sectors are expected to grow and why? What products are in pipeline and how would they impact sector growth? This report will also provide an insight into key studies and trials being held, with up-to date results and analysis.
An understanding of the emerging technologies and knowledge of upcoming companies and their product offerings will aid in the strategic planning for investors, manufacturers, regulators, payers/providers as well as analysts tracking this industry.
A strong understanding of the key trends to impact the medical equipment industry will prove to be a decisive factor in strategic planning and decision making for all involved in the value chain - investors, manufacturers, distributors, regulators, payer/providers and analysts tracking this industry.

Scope

The report covers information and analysis on product and technology launched at the conference
The report provides market size data and information on the interventional cardiology market with sub-segment level information for 4 segments namely Cardiac Catheters, Coronary Stent, PTCA Baloon, Intra Cardiac Closure Devices
Analysis and review of the key products and technologies within each segment and sub - segments that will impact the future of interventional cardiology
Review of key industry trends, events which are likely to impact and change the dynamics of the global interventional cardiology markets in the long run.
In-depth analysis of the studies and clinical trials presented at the conference
List of key companies presenting at the conference with company and product profiles
The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Our team of industry experts

Reasons to buy

Develop business strategies by understanding the trends shaping and driving the global medical equipment industry.
Organize your sales and marketing efforts by identifying the prevalent and expected competitive landscape in different medical equipment markets.
Design and develop your product development, marketing and sales strategies by identifying the market segments poised for a strong growth.
Identify key players who are best positioned to take advantage of the emerging market opportunities.
Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
What’s the next being thing in the interventional cardiology market landscape? - Identify, understand and capitalize. SHOW LESS READ MORE >

1 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Viewpoint 8
2.1 Summary 8
3 Transcatheter Cardiovascular Therapeutics 2008 - Post Conference Review 9
3.1 Background 9
4 TCT 2008 - Interventional Cardiology Outlook 10
4.1 Market Profile 10
4.2 Clinical Trial Information 11
4.3 Technology Showcase - Bioabsorbable Stents 15
4.3.1 Absorbable Metal Stent (AMS) 15
4.3.2 Fully Bioabsorbable Drug Eluting Coronary Stent 16
4.4 Competitive Landscape 18
4.4.1 Abbott Vascular 18
4.4.2 Boston Scientific Corporation 19
4.4.3 OrbusNeich 20
4.4.4 XTENT Inc. 21
4.4.5 CeloNova Biosciences 22
5 TCT 2008- Cardiac Rhythm Management & Electrophysiology Outlook 24
5.1 Market Overview 24
5.2 Clinical Trials - Details and Comparisons 25
5.3 Competitive Landscape 25
5.3.1 Boston Scientific 25
5.3.2 Medtronic, Inc. 27
5.3.3 St. Jude Medical, Inc 28
5.3.4 Zoll Medical Corporation 29
5.3.5 Atritech 29
6 TCT 2008 - Peripheral Vascular Devices Outlook 31
6.1 Market Overview 31
6.2 Competitive Landscape 31
6.2.1 AngioScore, Inc 31
6.2.2 Cordis Corporation 33
6.2.3 Genesis Medical Interventional, Inc 33
6.2.4 Lumen Biomedical 33
6.2.5 Possis Medical 36
7 TCT 2008 - Vascular Assist Devices Outlook 37
7.1 Market Overview 37
7.2 Clinical Trials - Details and Comparisons 37
7.3 Competitive Landscape 38
7.3.1 HeartWare 38
7.3.2 ABIOMED, Inc 39
7.3.3 Cardiac Assist, Inc 42
8 TCT 2008 - Prosthetic Heart Valves Outlook 43
8.1 Market Overview 43
8.2 Technology Showcase - Transcatheter Valves 44
8.3 Competitive Landscape 45
8.3.1 Edwards LifeSciences 45
8.3.2 CoreValve 46
8.3.3 Mitralign 47
9 TCT 2008- Cardiovascular Diagnostic and Imaging Devices Outlook 49
9.1 Market Overview 49
9.2 Technology Showcase - Computed Tomography Angiography (CTA) 49
9.3 Competitive Landscape 50
9.3.1 Bracco Diagnostics 50
9.3.2 Angel Medical Systems, Inc 50
9.3.3 CardioMEMS, Inc. 51
9.3.4 GE Healthcare 52
9.3.5 Paieon, Inc 53
9.3.6 Philips Medical Systems 53
9.3.7 Siemens Medical Solutions 54
9.3.8 Toshiba America Medical Systems, Inc 55
9.3.9 Vital Images Inc. 56
9.3.10 Volcano Corporation 56
10 TCT 2008 - Patent Foramen Ovale (PFO) Closure Outlook 59
10.1 Market Overview 59
10.2 Clinical Trials 59
10.3 Competitive Landscape 59
10.3.1 AGA Medical Corporation 59
10.3.2 Coherex Medical 60
10.3.3 NMT Medical 61
11 TCT 2008 - Vascular Closure Devices Outlook 64
11.1 Market Overview 64
11.2 Competitive Landscape 64
11.2.1 AccessClosure, Inc 64
11.2.2 Cardiva Vascular 65
12 Outlook and Implications 66
12.1 Changes in Healthcare Costs and Spending 66
12.2 Key Takeaways 66
13 Appendix 67
13.1 Methodology 67
13.2 About Us 67
13.3 Contact Us 67
13.4 Disclaimer 67

Executive Summary

1.1 List of Tables
Table 1: Drug Eluting Stents, Clinical Trial Comparison - 1 11
Table 2: Drug Eluting Stents, Clinical Trial Comparison - 2 12
Table 3: Thunder Trial - Target Lesion Revascularization Rates 13
Table 4: Key Companies with Bioabsorbable Stents in Pipeline 15
Table 5: ABSORB Clinical Trial Details 17
Table 6: TAXUS Atlas Workhorse Study, Three Year Follow up Results 20
Table 7: CUSTOM I Clinical Trial Details 22
Table 8: Cognis and Teligen Clinical Trial Details 27
Table 9: Watchman Left Atrial Appendage System-Clinical Trials 30
Table 10: Angiosculpt PTA Scoring Balloon Catheter Clinical Trial details 32
Table 11: FiberNet Embolic Protection System-Clinical Trial Details 34
Table 12: PROTECT I Clinical Trial Details 40
Table 13: PROTECT II Clinical Trial Details 41
Table 14: Heart Valves-Product Matrix 44
Table 15: PARTNER Clinical Trial Details 46
Table 16: ReValving® System Clinical Trial Details 47
Table 17: Mitralign Percutaneous Annuloplasty System Clinical Trials 48
Table 18: Comparison of the Combination of CTA and SPECT Perfusion versus Angiography 49
Table 19: CHAMPION Clinical Trial Details 51
Table 20: HF Pressure Measurement System Clinical Trial Details 52
Table 21: RESPECT Trial Details 60
Table 22: Pipeline Product Details 62
Table 23: STARFlex Clinical Trial Details 63